Cell Screening Device Maker DVS Takes $14.6 Million, Targets Pharma As Customers
This article was originally published in The Pink Sheet Daily
Executive Summary
Spun out of the University of Toronto, the young start-up looked to Silicon Valley and corporate pharma investors for capital.